Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jul 2010

Sun Tong, Lee Gwo-Shu Mary, Werner Lillian, Pomerantz Mark, Oh William K, Kantoff Philip W, Freedman Matthew L

Abstract excerpt

BACKGROUND: Sex steroid hormone receptors mediate essential processes in normal prostate growth and contribute to prostate cancer development. METHOD: In this study, we investigated the association between common inherited variation of the AR, ESR1, and ESR2 genes and two clinically relevant trai...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen Receptor alpha
Share to Estrogen Receptor beta

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Neoplasm Invasiveness

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Receptors, Androgen

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 20615892
DOI: 10.1158/1055-9965.EPI-10-0216
PMCID: PMC3755451

Genes

ESR1
ESR2
IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20615892-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.PMID 20615892Read ↗

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.Semantic proximity Read ↗

Association between estrogen and androgen receptor genes and prostate cancer risk.Semantic proximity Read ↗

The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.Semantic proximity Read ↗

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortiaSemantic proximity Read ↗

Inherited susceptibility for aggressive prostate cancer.Semantic proximity Read ↗

Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.Semantic proximity Read ↗

Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.Semantic proximity Read ↗

Established prostate cancer susceptibility variants are not associated with disease outcome.Semantic proximity Read ↗

Identification and characterization of estrogen receptor variants in prostate cancer cell lines.Semantic proximity Read ↗

Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms.Semantic proximity Read ↗

Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.